Annual Accounts Payable
$12.91 M
-$2.83 M-17.98%
December 31, 2024
Summary
- As of February 26, 2025, TXG annual accounts payable is $12.91 million, with the most recent change of -$2.83 million (-17.98%) on December 31, 2024.
- During the last 3 years, TXG annual accounts payable has fallen by -$4.44 million (-25.60%).
- TXG annual accounts payable is now -40.23% below its all-time high of $21.60 million, reached on December 31, 2022.
Performance
TXG Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$12.91 M
-$13.30 M-50.75%
December 31, 2024
Summary
- As of February 26, 2025, TXG quarterly accounts payable is $12.91 million, with the most recent change of -$13.30 million (-50.75%) on December 31, 2024.
- Over the past year, TXG quarterly accounts payable has dropped by -$13.30 million (-50.75%).
- TXG quarterly accounts payable is now -97.57% below its all-time high of $531.18 million, reached on December 1, 2014.
Performance
TXG Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
TXG Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.0% | -50.8% |
| 3 y3 years | -25.6% | -50.8% |
| 5 y5 years | -0.9% | -50.8% |
TXG Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.2% | at low | -56.0% | at low |
| 5 y | 5-year | -40.2% | +174.1% | -56.0% | +174.1% |
| alltime | all time | -40.2% | +174.1% | -97.6% | +174.1% |
10x Genomics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $12.91 M(-18.0%) | $12.91 M(-50.7%) |
| Sep 2024 | - | $26.21 M(+23.4%) |
| Jun 2024 | - | $21.25 M(+5.1%) |
| Mar 2024 | - | $20.22 M(+28.5%) |
| Dec 2023 | $15.74 M(-27.1%) | $15.74 M(-16.4%) |
| Sep 2023 | - | $18.84 M(-18.5%) |
| Jun 2023 | - | $23.12 M(-21.1%) |
| Mar 2023 | - | $29.32 M(+35.7%) |
| Dec 2022 | $21.60 M(+24.5%) | $21.60 M(+0.0%) |
| Sep 2022 | - | $21.59 M(-19.2%) |
| Jun 2022 | - | $26.73 M(+41.0%) |
| Mar 2022 | - | $18.96 M(+9.3%) |
| Dec 2021 | $17.35 M(+268.5%) | $17.35 M(+1.8%) |
| Sep 2021 | - | $17.04 M(+5.3%) |
| Jun 2021 | - | $16.18 M(+3.9%) |
| Mar 2021 | - | $15.58 M(+230.8%) |
| Dec 2020 | $4.71 M | $4.71 M(-50.4%) |
| Sep 2020 | - | $9.49 M(-4.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $9.92 M(-26.6%) |
| Mar 2020 | - | $13.51 M(+3.7%) |
| Dec 2019 | $13.03 M(+48.2%) | $13.03 M(+8.9%) |
| Sep 2019 | - | $11.96 M(+26.8%) |
| Jun 2019 | - | $9.43 M(+7.2%) |
| Dec 2018 | $8.79 M(+61.5%) | $8.79 M(-96.0%) |
| Dec 2017 | $5.44 M | - |
| Sep 2017 | - | $220.81 M(+12.6%) |
| Jun 2017 | - | $196.14 M(-0.3%) |
| Mar 2017 | - | $196.78 M(-1.2%) |
| Dec 2016 | - | $199.08 M(+24.1%) |
| Sep 2016 | - | $160.43 M(-8.3%) |
| Jun 2016 | - | $174.86 M(-4.9%) |
| Mar 2016 | - | $183.85 M(-9.5%) |
| Dec 2015 | - | $203.13 M(-44.3%) |
| Sep 2015 | - | $364.48 M(-20.0%) |
| Jun 2015 | - | $455.75 M(+14.7%) |
| Mar 2015 | - | $397.45 M(-25.2%) |
| Dec 2014 | - | $531.18 M |
FAQ
- What is 10x Genomics annual accounts payable?
- What is the all time high annual accounts payable for 10x Genomics?
- What is 10x Genomics annual accounts payable year-on-year change?
- What is 10x Genomics quarterly accounts payable?
- What is the all time high quarterly accounts payable for 10x Genomics?
- What is 10x Genomics quarterly accounts payable year-on-year change?
What is 10x Genomics annual accounts payable?
The current annual accounts payable of TXG is $12.91 M
What is the all time high annual accounts payable for 10x Genomics?
10x Genomics all-time high annual accounts payable is $21.60 M
What is 10x Genomics annual accounts payable year-on-year change?
Over the past year, TXG annual accounts payable has changed by -$2.83 M (-17.98%)
What is 10x Genomics quarterly accounts payable?
The current quarterly accounts payable of TXG is $12.91 M
What is the all time high quarterly accounts payable for 10x Genomics?
10x Genomics all-time high quarterly accounts payable is $531.18 M
What is 10x Genomics quarterly accounts payable year-on-year change?
Over the past year, TXG quarterly accounts payable has changed by -$13.30 M (-50.75%)